These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist. Egan AP; Taggart JR; Bender CM Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124 [TBL] [Abstract][Full Text] [Related]
3. [Ondansetron--a 5HT 3 receptor antagonist for the treatment of nausea and vomiting induced by cytostatics and radiotherapy]. Herrstedt J; Ersbøll J; Dombernowsky P Ugeskr Laeger; 1991 Apr; 153(18):1292-5. PubMed ID: 1827555 [No Abstract] [Full Text] [Related]
4. Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics. Mitchell PL; Evans BD; Allan SG; Forgeson GV; Mak D; Neave L; Humm G; Langley G; Dickson D; Harvey VJ N Z Med J; 1992 Mar; 105(929):73-5. PubMed ID: 1532054 [TBL] [Abstract][Full Text] [Related]
5. Is ondansetron a less effective antiemetic against moderately emetic as compared with highly emetic chemotherapy? Dundee JW; McMillan CM; Yang J; Wright PM Br J Clin Pharmacol; 1992 Feb; 33(2):200-1. PubMed ID: 1532323 [TBL] [Abstract][Full Text] [Related]
6. [New, in Austria registered specialty drugs. Zofran (Ondansetron, Glaxo)]. Erben M Wien Klin Wochenschr; 1991; 103(19):594-601. PubMed ID: 1836917 [No Abstract] [Full Text] [Related]
7. Enhancement of the antiemetic action of ondansetron by transcutaneous electrical stimulation of the P6 antiemetic point, in patients having highly emetic cytotoxic drugs. McMillan C; Dundee JW; Abram WP Br J Cancer; 1991 Nov; 64(5):971-2. PubMed ID: 1834156 [No Abstract] [Full Text] [Related]
8. Antiemetics for cancer chemotherapy-induced nausea and vomiting. Summary and table. Palmer KJ; Poole R Drugs R D; 1999 Oct; 2(4):237-9. PubMed ID: 10659397 [No Abstract] [Full Text] [Related]
9. Parenteral ondansetron for the treatment of chemotherapy- and radiation-induced nausea and vomiting. Burnette PK; Perkins J Pharmacotherapy; 1992; 12(2):120-31. PubMed ID: 1533280 [TBL] [Abstract][Full Text] [Related]
10. Ondansetron: a new entity in emesis control. Graves T DICP; 1990 Nov; 24(11 Suppl):S51-4. PubMed ID: 2148659 [TBL] [Abstract][Full Text] [Related]
11. Management of nausea and vomiting caused by anticancer drugs: state of the art. Pisters KM; Kris MG Oncology (Williston Park); 1992 Feb; 6(2 Suppl):99-104. PubMed ID: 1532744 [TBL] [Abstract][Full Text] [Related]
12. Ondansetron vs dexamethasone for chemotherapy-induced emesis. Lancet; 1991 Aug; 338(8765):478-9. PubMed ID: 1714531 [No Abstract] [Full Text] [Related]
14. Oncology Patient Evidence-Based Notes (OPEN): antiemetics for chemotherapy-induced nausea and vomiting. Cope D Clin J Oncol Nurs; 2003; 7(4):461-2. PubMed ID: 12929282 [No Abstract] [Full Text] [Related]
15. [The use of antiemetics in cancer chemotherapy]. Ghosn M; Droz JP J Med Liban; 1992; 40(2):106-7. PubMed ID: 1339878 [TBL] [Abstract][Full Text] [Related]
17. Emesis as a complication of cancer chemotherapy: pathophysiology, importance, and treatment. Graves T Pharmacotherapy; 1992; 12(4):337-45. PubMed ID: 1387707 [TBL] [Abstract][Full Text] [Related]
18. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy. Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140 [TBL] [Abstract][Full Text] [Related]
19. [The magic plant as an antiemetic. Cannabinoids for treatment of nausea and vomiting]. Kreutz S Pharm Unserer Zeit; 2007; 36(5):389-92. PubMed ID: 17722146 [No Abstract] [Full Text] [Related]
20. Ondansetron, a new antiemetic therapy for oncology. An overview. Lip H Scand J Gastroenterol Suppl; 1990; 178():55-61. PubMed ID: 2148983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]